Exchange: NASDAQ·Updated 08:24 AM EDT

GRDX GridAI Technologies Corp.

$4.37
$0.02
(0.46%)
Pre-Market
Prev Close $4.39
Mkt Cap$31.31M
Vol2,219.00

About GRDX

GridAI Technologies Corp. is a diversified technology and life sciences company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide. The company was founded on January 30, 2014 and is headquartered in Boca Raton, FL.
48

Neutral Sentiment

How do you feel about GRDX?

Advertisement|Remove ads.